Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Starpharma.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Anteris’ 3D heart valve shows consistent results; as Nyrada announces a new lead drug
Health & Biotech
ASX Health Stocks: OncoSil to commence trial; Korea and Malaysia next stops for these biotechs
News
CLOSING BELL: The ASX engine rooms roar to life, delivering a +1.2% touch worthy of Midas himself
News
Market Highlights: SBF finds $375m down the back of mum and dad’s couch, and 5 ASX small caps to watch today
Health & Biotech
ASX Health Stocks: Clarity reveals Phase 1 success; Starpharma and Oncosil head for Asia
Health & Biotech
ASX Health Stocks: These three ASX biotechs get to strut their stuff with Bell Potter and Nature Portfolio
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
ASX Health Stocks: Antisense commences trial dosing, Shine lawyers deliver historic $300m settlement
Health & Biotech
ASX Health Stocks: Cann’s Mildura cannabis facility gets GMP licence, unlocking export markets
Health & Biotech
ASX Health Stocks: Imugene begins Phase 1 trial of its cancer-fighting virus
Health & Biotech
ASX Health Stocks: UK FSA welcomes Cann’s CBD capsules onto its approved list
Health & Biotech
ASX Health Stocks: OncoSil up 15pc on German device funding; Starpharma expands to Middle East
Health & Biotech
ASX Health Stocks: Neuren stock price up 100pc on positive Phase 3 results
Health & Biotech
ASX Health Stocks: Alcidion wins Aussie government contract, while Resonance seeks US FDA nod
Health & Biotech
ASX Health Stocks: After TGA approval in Australia, Telix now gets license to sell in Brazil
Health & Biotech
ASX Health Stocks: Rhythm Biosciences scores CE Mark approval, shares jump
Health & Biotech